Meritor (MTOR)

MTOR NEWS

Against "Against Life Extension" By Alex - 1 month ago

Dr. Fukuyama, when you plant the word "against" adjacent to the phrase "life extension," you've earned an "F" in Longevity Strawman Arguments, Volume 1. The project of longevity is ethically imperati… [+4869 chars]...

Read more
Anti-aging drug as good for cell health as dieting or fasting By Bronwyn - 2 weeks ago

A large meta-analysis has found that the drug leading the charge in anti-aging science is just as effective in protecting cells and cognitive function as cutting calories or intermittent fasting (IF)… [+4372 chars]...

Read more
U.S. Seniors Nearly Double Cannabis Use In Just Two Years, Study Finds By Site Author - 1 month ago

a series of photos showing a senior farmer growing cannabis for medical purposes getty U.S. Seniors are turning to cannabis more than ever, with use nearly doubling in the past two years, a new stu… [+3985 chars]...

Read more
Biodexa Announces Activation of First Clinical Study Site for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP) By Biodexa - 1 week ago

June 25, 2025 Biodexa Announces Activation of First Clinical Study Site for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP) Biodexa Pharmaceuticals PLC (Biodexa or the Company), (Nasd… [+8400 chars]...

Read more
Biodexa Unveils "Serenta" as the Name of its Upcoming Phase 3 Study In Familial Adenomatous Polyposis (FAP) By Biodexa - 1 week ago

June 23, 2025 Biodexa Unveils "Serenta" as the Name of its Upcoming Phase 3 Study In Familial Adenomatous Polyposis (FAP) Biodexa Pharmaceuticals PLC (Biodexa or the Company), (Nasdaq: BDRX), a cli… [+6051 chars]...

Read more
Palvella Therapeutics Granted Sixth U.S. Patent Covering 0.1–20% Anhydrous Compositions of Rapamycin and Other mTOR Inhibitors By Site Author - 2 weeks ago

New intellectual property builds on Palvellas multi-layered exclusivity strategy Patent term expected through at least 2038 WAYNE, Pa., June 18, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella The… [+7659 chars]...

Read more
Top Stock
CurrencyPrice Chg
BA
215.92 3.89
1.83%
CVX
148.37 0.39
0.26%
CAT
397.86 -0.57
-0.14%
INTC
22.49 0.61
2.79%
MSFT
498.84 7.75
1.58%
DIS
124 1.02
0.83%
DOW
28.46 -0.27
-0.94%
CSCO
69.37 0.78
1.14%
GS
723.68 7.79
1.09%